Search results
Harry Jowsey reveals skin cancer diagnosis at age 26 — here’s what to know about the ‘scary’ disease
New York Post· 4 days agoThe Centers for Disease Control and Prevention say that sun safety is key to reduce the risk of all...
Perspective | I’m in my early 20s. Why do I have breast cancer?
Washington Post· 4 days agoCancer among young patients isn’t common, but it’s on the rise. For young patients like me, it’s...
Study identifies driver of liver cancer that could be target for treatment
Medical Xpress· 5 days agoThe molecule, said the researchers, could be a target for cancer treatment in the future. Hepatocellular carcinoma is a type of cancer
Your expert guide to melanomas and how to spot them
The Telegraph via Yahoo News· 5 days agoIf you have noticed a lingering spot somewhere on your skin, it would be wise not to dismiss it, especially if there’s something unusual about its...
Exeliom to focus on gastric cancer landscape with immune modulating drug
Clinical Trials Arena via Yahoo Finance· 5 days agoThe other Phase II trials will be in non-small cell Lung cancer (NSCLC), led by the Lille University...
USPSTF Recommendation: Screening for Breast Cancer
Journal of the American Medical Association· 1 day agoThis 2024 Recommendation Statement from the US Preventive Services Task Force recommends biennial screening mammography for women aged 40 to 74 years (B recommendation) and concludes that evidence ...
Cabozantinib promising for advanced adrenocortical carcinoma
Medical Xpress· 2 days agoFor patients with advanced adrenocortical carcinoma, cabozantinib shows promising efficacy,...
New study provides genomic insights into kidney cancer risk
National Cancer Institute· 5 days agoIn a new analysis of genetic susceptibility to kidney cancer, an international team of researchers...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 8 hours agoDelhi, May 01, 2024 (GLOBE NEWSWIRE) -- Global CD70 Targeting Therapies Market Opportunity & Clinical Trials Insight 2024 Report Highlights: CD70 Targeting Therapies In Clinical Trials: > 20 TherapiesCD 70 Targeting Therapies Clinical Trials
Recurrence Data for Narrow Band Imaging™ (NBI™) Technology Show Value in the Fight Against...
Journal Gazette & Times-Courier· 7 days ago"Without dyes, without any change to the patient's standard cystoscopy, and with only a push of a button, urologists can better visualize a lesion, and potentially contribute to reduced recurrence ...
